Beneficial effect of dehydroepiandrosterone on pulmonary hypertension in a rodent model of pulmonary hypertension in infants
Authors:
- Eric Dumas de la RoqueEREric Dumas de la Roque
- Jean-François QuignardJQJean-François Quignard
- Thomas DucretTDThomas Ducret
- Diana DahanDDDiana Dahan
- Arnaud CourtoisACArnaud Courtois
- Hugues BegueretHBHugues Begueret
- Roger MarthanRMRoger Marthan
- Jean-Pierre SavineauJSJean-Pierre Savineau
- 6 May 2013
- journal article
- Published by Springer Nature in Pediatric Research
- Vol. 74 (2) , 163-169
Abstract
Pulmonary hypertension (PH) is a disease that affects the adult or infant population. Dehydroepiandrosterone (DHEA), a steroid hormone, has been previously shown to prevent and to reverse PH in an adult rat model. We thus investigated its effect in a rat-pup model of chronic hypoxic PH. Animals were maintained for 3 wk in a hypobaric chamber to induce PH, with or without concomitant treatment with DHEA (30 mg/kg every alternate day). DHEA significantly reduced mean pulmonary artery pressure (measured by right cardiac catheterization), pulmonary artery remodeling (evaluated by histology), and right-ventricular hypertrophy (measured by echography and by the Fulton index). At the level of the pulmonary artery smooth muscle cell (PASMC), DHEA increased activity and expression of the large-conductance Ca2+-activated potassium channel (BKCa) (assessed by means of the patch clamp technique). DHEA also inhibited both serotonin- and KCl-induced contraction and smooth muscle cell proliferation. Collectively, these results indicate that DHEA prevents PH in infant rats and may therefore be clinically relevant for the management of PH in human infants.Keywords
This publication has 38 references indexed in Scilit:
- Dehydroepiandrosterone (DHEA) inhibits voltage-gated T-type calcium channelsBiochemical Pharmacology, 2012
- Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertensionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Stretch-activated channels in pulmonary arterial smooth muscle cells from normoxic and chronically hypoxic ratsCell Calcium, 2010
- Basic Science of Pulmonary Arterial Hypertension for CliniciansCirculation, 2010
- Assessment of endpoints in the pediatric population: congenital heart disease and idiopathic pulmonary arterial hypertensionCurrent Opinion in Pulmonary Medicine, 2010
- Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertensionBritish Journal of Pharmacology, 2009
- Dehydroepiandrosterone Reverses Systemic Vascular Remodeling Through the Inhibition of the Akt/GSK3-β/NFAT AxisCirculation, 2009
- Cellular and Molecular Basis of Pulmonary Arterial HypertensionJACC, 2009
- Novel interactions between the 5‐HT transporter, 5‐HT1B receptors and Rho kinase in vivo and in pulmonary fibroblastsBritish Journal of Pharmacology, 2008
- Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosteroneAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008